Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NervGen Pharma | TSXV | Healthcare | Biotechnology & Medical Research | $287.68M | -14.1x | 1.25 | $3.95 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Eupraxia Pharmaceuticals | Toronto | Healthcare | Biotechnology & Medical Research | $273.53M | -5.2x | -0.21 | $7.63 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bright Minds Biosciences | CSE | Healthcare | Biotechnology & Medical Research | $247.63M | -61.3x | -1.36 | $34.96 | -3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cybin | CBOE Canada | Healthcare | Biotechnology & Medical Research | $240.92M | -1.9x | -0.05 | $10.38 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ME Therapeutics Holdings | CBOE Canada | Healthcare | Biotechnology & Medical Research | $236.12M | -217.5x | -6.13 | $7.98 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Oncolytics Biotech | Toronto | Healthcare | Biotechnology & Medical Research | $154.56M | -4x | 13.22 | $1.60 | 6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ZEN Graphene | TSXV | Healthcare | Biotechnology & Medical Research | $153.92M | -15.1x | -0.92 | $1.47 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cardiol Therapeutics | Toronto | Healthcare | Biotechnology & Medical Research | $148.77M | -3.8x | 1.68 | $1.80 | -3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Satellos Bioscience | Toronto | Healthcare | Biotechnology & Medical Research | $102.26M | -1.8x | 0.52 | $0.58 | -6.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Onco Innovations | CSE | Healthcare | Biotechnology & Medical Research | $100.16M | -10.5x | $1.90 | -10.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Quantum BioPharma | CBOE Canada | Healthcare | Biotechnology & Medical Research | $85.57M | -1.5x | -0.16 | $24.81 | -6.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Helix BioPharma Corp. | Toronto | Healthcare | Biotechnology & Medical Research | $71.93M | -5.2x | 0.29 | $0.97 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medicenna | Toronto | Healthcare | Biotechnology & Medical Research | $70.04M | -5.5x | -0.1 | $0.84 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
KDA Group | TSXV | Healthcare | Biotechnology & Medical Research | $67.72M | -7.7x | 0.05 | $0.35 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sona Nanotech | CSE | Healthcare | Biotechnology & Medical Research | $61.90M | -19x | -1.38 | $0.55 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
NurExone Biologic | TSXV | Healthcare | Biotechnology & Medical Research | $60.01M | -6.4x | 1.94 | $0.75 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Zyus Life Sciences | TSXV | Healthcare | Biotechnology & Medical Research | $55.84M | -1.5x | -0.06 | $0.72 | 5.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Microbix Biosystems Inc. | Toronto | Healthcare | Biotechnology & Medical Research | $41.47M | 26.5x | -0.43 | $0.30 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
MustGrow Biologics | TSXV | Healthcare | Biotechnology & Medical Research | $39.81M | -9.4x | 0.01 | $0.76 | -2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Defence Therapeutics | CBOE Canada | Healthcare | Biotechnology & Medical Research | $37.21M | -9.7x | -0.13 | $0.68 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Thiogenesis Therapeutics | TSXV | Healthcare | Biotechnology & Medical Research | $35.66M | -8.7x | -0.34 | $0.77 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Avicanna | Toronto | Healthcare | Biotechnology & Medical Research | $27.31M | -10.8x | -0.15 | $0.24 | -9.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hemostemix Inc | TSXV | Healthcare | Biotechnology & Medical Research | $20.34M | -4.1x | 0.08 | $0.14 | 3.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BioMark Diagnostics Inc | CSE | Healthcare | Biotechnology & Medical Research | $19.88M | -73.5x | -0.2 | $0.35 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Briacell Therapeutics | Toronto | Healthcare | Biotechnology & Medical Research | $18.91M | -0.2x | 0.02 | $2.79 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BetterLife Pharma Inc | CBOE Canada | Healthcare | Biotechnology & Medical Research | $15.70M | -5.6x | -0.14 | $0.10 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
COSCIENS Biopharma | Toronto | Healthcare | Biotechnology & Medical Research | $15.04M | -0.6x | 0 | $4.78 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sharp Therapeutics | TSXV | Healthcare | Biotechnology & Medical Research | $14.99M | -4.1x | -0.03 | $0.50 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Innovotech | TSXV | Healthcare | Biotechnology & Medical Research | $14.96M | 38x | 0.14 | $0.30 | 11.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Rakovina Therapeutics | TSXV | Healthcare | Biotechnology & Medical Research | $14.59M | -1.1x | 0.05 | $0.69 | -5.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Resverlogix Corp. | Toronto | Healthcare | Biotechnology & Medical Research | $12.81M | -0.7x | 0.02 | $0.05 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medicure | TSXV | Healthcare | Biotechnology & Medical Research | $12.63M | -7.2x | 0.13 | $1.21 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Principal Tech | TSXV | Healthcare | Biotechnology & Medical Research | $12M | -3.3x | 5.01 | $0.26 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Marvel Biosciences | TSXV | Healthcare | Biotechnology & Medical Research | $11M | -4x | -0.22 | $0.18 | 5.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Telo Genomics | TSXV | Healthcare | Biotechnology & Medical Research | $10M | -3.1x | -0.15 | $0.10 | 11.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Biovaxys Technology | CSE | Healthcare | Biotechnology & Medical Research | $8.80M | -1.5x | -0.04 | $0.03 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Moss Genomics | CSE | Healthcare | Biotechnology & Medical Research | $8.65M | $0.15 | 20% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Revive Therapeutics | CBOE Canada | Healthcare | Biotechnology & Medical Research | $8.50M | -3.1x | -0.11 | $0.02 | 33.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Quest PharmaTech | TSXV | Healthcare | Biotechnology & Medical Research | $5.07M | -30x | -0.22 | $0.03 | -14.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
XORTX Therapeutics | TSXV | Healthcare | Biotechnology & Medical Research | $4.89M | -3x | -0.04 | $1.29 | 13.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Restart Life Sciences | CBOE Canada | Healthcare | Biotechnology & Medical Research | $3.37M | -2.2x | -0.14 | $0.10 | 5.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
MindBio Therapeutics | CSE | Healthcare | Biotechnology & Medical Research | $2.84M | -0.8x | -0.17 | $0.010 | -50% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Psyence | CBOE Canada | Healthcare | Biotechnology & Medical Research | $2.45M | -0x | 0 | $0.17 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Algernon Pharma | CSE | Healthcare | Biotechnology & Medical Research | $2.23M | 7.9x | 0.08 | $0.06 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Waverley Pharma | TSXV | Healthcare | Biotechnology & Medical Research | $1.89M | -2.3x | -0.04 | $0.04 | 16.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Appili Therapeutics | Toronto | Healthcare | Biotechnology & Medical Research | $1.82M | -0.7x | -0.02 | $0.01 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Entheon Biomedical | CSE | Healthcare | Biotechnology & Medical Research | $1.39M | -2.4x | -0.32 | $0.10 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ramm Pharma | CSE | Healthcare | Biotechnology & Medical Research | $1.19M | -0.1x | 0 | $0.010 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
EGF Theramed Health Corp | CSE | Healthcare | Biotechnology & Medical Research | $1.10M | -2.8x | 0.1 | $0.09 | -5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Vaxil Bio Ltd | TSXV | Healthcare | Biotechnology & Medical Research | $547.92K | -2.9x | 1.8 | $0.20 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |